Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
Abstract Triple negative breast cancer (TNBC) is characterized by an aggressive biological behavior in the absence of a specific target agent. Nicotinamide has recently been proven to be a novel therapeutic agent for skin tumors in an ONTRAC trial. We performed combinatory transcriptomic and in-dept...
Guardado en:
Autores principales: | Ji Young Kim, Hyebin Lee, Jongmin Woo, Wang Yue, Kwangsoo Kim, Seongmin Choi, Ja-June Jang, Youngsoo Kim, In Ae Park, Dohyun Han, Han Suk Ryu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9c37b2e0b7134150881904106462bd3e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ketohexokinase-A acts as a nuclear protein kinase that mediates fructose-induced metastasis in breast cancer
por: Jiyoung Kim, et al.
Publicado: (2020) -
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
por: Joanna Ratajczak, et al.
Publicado: (2016) -
Metabolic engineering of Escherichia coli for biosynthesis of β‐nicotinamide mononucleotide from nicotinamide
por: Yang Liu, et al.
Publicado: (2021) -
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
por: Brian D. Lehmann, et al.
Publicado: (2021) -
Single-cell trajectories reconstruction, exploration and mapping of omics data with STREAM
por: Huidong Chen, et al.
Publicado: (2019)